Task: Answer the multiple choice question.
Question: Which drug has a 1.160\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1cc(CC(C#N)(CO)c2nc3ccccc3[nH]2)ccc1OC(F)F
b CC(C)NC(=O)c1onc(CSc2ccc(C(C)C)cc2)c1C(=O)O
Answer: a. COc1cc(CC(C#N)(CO)c2nc3ccccc3[nH]2)ccc1OC(F)F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(CC(C#N)(CO)c2nc3ccccc3[nH]2)ccc1OC(F)F
COc1cc(CC(C#N)(CO)c2nc3ccccc3[nH]2)ccc1OC(F)F
2-(1H-benzimidazol-2-yl)-2-[[4-(difluoromethoxy)-3-methoxyphenyl]methyl]-3-hydroxypropanenitrile